Exodus Point Capital Management, LP Tyra Biosciences, Inc. Transaction History
Exodus Point Capital Management, LP
- $14.7 Billion
- Q2 2024
A detailed history of Exodus Point Capital Management, LP transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 170,717 shares of TYRA stock, worth $3.68 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
170,717
Previous 272,150
37.27%
Holding current value
$3.68 Million
Previous $4.46 Million
38.83%
% of portfolio
0.02%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding TYRA
# of Institutions
78Shares Held
43.4MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA10.4MShares$225 Million2.51% of portfolio
-
Boxer Capital, LLC San Diego, CA6.45MShares$139 Million5.73% of portfolio
-
Bvf Inc San Francisco, CA4.66MShares$101 Million2.28% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.41MShares$95.2 Million85.38% of portfolio
-
Nextech Invest Ag4.06MShares$87.5 Million12.24% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $906M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...